Pondy Oxides And Chemicals Limited (POCL.NS)
Chennai, IN
Pondy Oxides And Chemicals Limited (POCL), an Indian enterprise founded in 1995 and based in Chennai, operates primarily as a secondary lead smelting company. It focuses on the manufacturing and distribution of various lead metals and alloys, along with zinc metal and zinc oxides, throughout India. The company's diverse product portfolio also includes master, tin, and babbit alloys, as well as essential additives for PVC applications. POCL primarily supplies its materials to manufacturers in the battery and chemical industries, in addition to producers of extruded and molded PVC goods. Beyond its domestic presence, the company actively exports its products to international markets, including Japan, South Korea, Thailand, Indonesia, and across the Middle East.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.49% | -10.00% | +5.61% | +13.74% | +1.28% | -10.36% | +72.44% | +283.95% | +283.95% | +283.95% | +283.95% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+43.8% ★ Q1'26: +78.6% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+108.6% ★ Q1'26: +124.4% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-2.7% Q1'26: +11.1% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+6.3% Q1'26: +5.3% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+14.6% ★ Q1'26: +23.9% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+8.9% Q1'26: +1.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.72× Q1'26: 0.16× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
Mar 2031 1 Rev. Ana. 1 EPS Ana. |
Mar 2032 1 Rev. Ana. 1 EPS Ana. |
Mar 2033 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.73B
est: 4.87B (-23.4%)
|
4.65B
est: 4.26B (+9.0%)
|
7.59B
est: 8.17B (-7.1%)
|
9.40B
est: 9.68B (-2.9%)
|
10.49B
est: 10.85B (-3.3%)
|
12.20B
est: 12.26B (-0.5%)
|
20.57B
est: 4.87B (+322.5%)
|
8.17B
8.17B – 8.17B
+67.9% YoY
|
8.17B
8.17B – 8.17B
+0.0% YoY
|
9.68B
9.68B – 9.68B
+18.4% YoY
|
10.85B
10.85B – 10.85B
+12.1% YoY
|
12.26B
12.26B – 12.26B
+13.0% YoY
|
29.92B
29.92B – 29.92B
+144.0% YoY
|
37.64B
37.64B – 37.64B
+25.8% YoY
|
49.13B
49.13B – 49.13B
+30.5% YoY
|
| EBITDA |
182.06M
est: 251.94M (-27.7%)
|
271.94M
est: 220.55M (+23.3%)
|
579.89M
est: 423.04M (+37.1%)
|
599.10M
est: 500.78M (+19.6%)
|
686.22M
est: 561.59M (+22.2%)
|
396.60M
est: 634.60M (-37.5%)
|
1.05B
est: 294.50M (+256.1%)
|
494.51M
494.51M – 494.51M
+67.9% YoY
|
494.51M
494.51M – 494.51M
+0.0% YoY
|
585.38M
585.38M – 585.38M
+18.4% YoY
|
656.47M
656.47M – 656.47M
+12.1% YoY
|
741.81M
741.81M – 741.81M
+13.0% YoY
|
1.81B
1.81B – 1.81B
+144.0% YoY
|
2.28B
2.28B – 2.28B
+25.8% YoY
|
2.97B
2.97B – 2.97B
+30.5% YoY
|
| EBIT |
158.15M
est: 214.26M (-26.2%)
|
235.80M
est: 187.56M (+25.7%)
|
541.80M
est: 359.77M (+50.6%)
|
556.79M
est: 425.89M (+30.7%)
|
634.88M
est: 477.61M (+32.9%)
|
311.73M
est: 539.70M (-42.2%)
|
882.18M
est: 256.79M (+243.5%)
|
431.18M
431.18M – 431.18M
+67.9% YoY
|
431.18M
431.18M – 431.18M
+0.0% YoY
|
510.42M
510.42M – 510.42M
+18.4% YoY
|
572.41M
572.41M – 572.41M
+12.1% YoY
|
646.82M
646.82M – 646.82M
+13.0% YoY
|
1.58B
1.58B – 1.58B
+144.0% YoY
|
1.99B
1.99B – 1.99B
+25.8% YoY
|
2.59B
2.59B – 2.59B
+30.5% YoY
|
| Net Income |
67.10M
est: 106.37M (-36.9%)
|
101.27M
est: 129.37M (-21.7%)
|
279.25M
est: 344.80M (-19.0%)
|
291.79M
est: 391.48M (-25.5%)
|
337.28M
est: 531.73M (-36.6%)
|
163.46M
est: 620.55M (-73.7%)
|
580.55M
est: 115.81M (+401.3%)
|
375.40M
375.40M – 375.40M
+224.1% YoY
|
375.40M
375.40M – 375.40M
+0.0% YoY
|
426.22M
426.22M – 426.22M
+13.5% YoY
|
578.92M
578.92M – 578.92M
+35.8% YoY
|
675.61M
675.61M – 675.61M
+16.7% YoY
|
1.33B
1.33B – 1.33B
+97.5% YoY
|
1.60B
1.60B – 1.60B
+20.2% YoY
|
2.01B
2.01B – 2.01B
+25.0% YoY
|
| SGA |
45.21M
est: 75.49M (-40.1%)
|
16.48M
est: 66.09M (-75.1%)
|
16.99M
est: 126.76M (-86.6%)
|
72.81M
est: 150.06M (-51.5%)
|
87.37M
est: 168.28M (-48.1%)
|
118.68M
est: 190.16M (-37.6%)
|
265.77M
est: 91.39M (+190.8%)
|
153.46M
153.46M – 153.46M
+67.9% YoY
|
153.46M
153.46M – 153.46M
+0.0% YoY
|
181.66M
181.66M – 181.66M
+18.4% YoY
|
203.72M
203.72M – 203.72M
+12.1% YoY
|
230.20M
230.20M – 230.20M
+13.0% YoY
|
561.69M
561.69M – 561.69M
+144.0% YoY
|
706.56M
706.56M – 706.56M
+25.8% YoY
|
922.30M
922.30M – 922.30M
+30.5% YoY
|
| EPS |
3.01
est: 3.86 (-22.1%)
|
4.54
est: 4.70 (-3.4%)
|
12.52
est: 12.52 (+0.0%)
|
13.09
est: 14.22 (-7.9%)
|
15.12
est: 19.31 (-21.7%)
|
7.32
est: 22.53 (-67.5%)
|
22.03
est: 3.86 (+470.4%)
|
12.52
12.52 – 12.52
+224.1% YoY
|
12.52
12.52 – 12.52
+0.0% YoY
|
14.22
14.22 – 14.22
+13.5% YoY
|
19.31
19.31 – 19.31
+35.8% YoY
|
22.53
22.53 – 22.53
+16.7% YoY
|
44.50
44.50 – 44.50
+97.5% YoY
|
53.50
53.50 – 53.50
+20.2% YoY
|
66.90
66.90 – 66.90
+25.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | VanEck India Growth Leaders ETF GLIN | 0.13% | 127.7K | 0.72% |
| 2 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.01% | 87.0K | 0.65% |
| 3 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.01% | 27.8K | 0.56% |
| 4 | State Street SPDR Portfolio Emerging Markets ETF SPEM | 0.01% | 1.12M | 0.07% |
| 5 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.01% | 36.8K | 0.44% |
| 6 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 395.1K | 0.39% |
| 7 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 293.9K | 0.29% |
| 8 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 191.5K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ashish Bansal | MD & Director | 26M | male |
| Anil Kumar Bansal | Whole-Time Director & Executive Chairman | 12M | male |
| Krishna Moorthi Kumaravel | Director of Finance, Whole-Time Director, Compliance Officer & Company Secretary | 6M | male |
| Vijay Balakrishnan | Chief Financial Officer | — | male |
| Mayank Sharma | President of Operations | — | male |
| Prabhakar | IT Head | — | male |
| Premji George | Group Head of Lead operations | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for POCL.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
